DK1967198T3 - Formuleringer indeholdende Cynara scolymus- og Phaseolus vulgaris-ekstrakter, der er anvendelige til behandling af obesitet - Google Patents

Formuleringer indeholdende Cynara scolymus- og Phaseolus vulgaris-ekstrakter, der er anvendelige til behandling af obesitet

Info

Publication number
DK1967198T3
DK1967198T3 DK07425132T DK07425132T DK1967198T3 DK 1967198 T3 DK1967198 T3 DK 1967198T3 DK 07425132 T DK07425132 T DK 07425132T DK 07425132 T DK07425132 T DK 07425132T DK 1967198 T3 DK1967198 T3 DK 1967198T3
Authority
DK
Denmark
Prior art keywords
cynara scolymus
obesity
phaseolus vulgaris
treatment
formulations containing
Prior art date
Application number
DK07425132T
Other languages
Danish (da)
English (en)
Inventor
Ezio Bombardelli
Gabriele Fontana
Andrea Giori
Paolo Morazzoni
Cesare Ponzone
Massimo Ronchi
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Application granted granted Critical
Publication of DK1967198T3 publication Critical patent/DK1967198T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
DK07425132T 2007-03-07 2007-03-07 Formuleringer indeholdende Cynara scolymus- og Phaseolus vulgaris-ekstrakter, der er anvendelige til behandling af obesitet DK1967198T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP07425132A EP1967198B1 (en) 2007-03-07 2007-03-07 Formulations containing cynara scolymus and phaseolus vulgaris extracts which are useful in the treatment of obesity

Publications (1)

Publication Number Publication Date
DK1967198T3 true DK1967198T3 (da) 2009-08-10

Family

ID=38229761

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07425132T DK1967198T3 (da) 2007-03-07 2007-03-07 Formuleringer indeholdende Cynara scolymus- og Phaseolus vulgaris-ekstrakter, der er anvendelige til behandling af obesitet

Country Status (20)

Country Link
US (2) US7887854B2 (sl)
EP (1) EP1967198B1 (sl)
JP (1) JP5355424B2 (sl)
KR (1) KR101456555B1 (sl)
CN (1) CN101641111B (sl)
AT (1) ATE431155T1 (sl)
AU (1) AU2008224057B2 (sl)
BR (1) BRPI0808563B1 (sl)
CA (1) CA2680078C (sl)
DE (1) DE602007001128D1 (sl)
DK (1) DK1967198T3 (sl)
ES (1) ES2323815T3 (sl)
HK (1) HK1121694A1 (sl)
IL (1) IL200709A (sl)
NO (1) NO339322B1 (sl)
PL (1) PL1967198T3 (sl)
PT (1) PT1967198E (sl)
RU (1) RU2453323C2 (sl)
SI (1) SI1967198T1 (sl)
WO (1) WO2008107184A1 (sl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20052450A1 (it) 2005-12-22 2007-06-23 Indena Spa Estratti di phaseolus vulgaris loro uso e formulazioni che li contengono
CN101874822A (zh) 2009-04-27 2010-11-03 玫琳凯有限公司 植物性抗痤疮制剂
EP2345646A1 (en) * 2010-01-14 2011-07-20 InterMed Discovery GmbH Use of tricyclic sesquiterpene lactones in the treatment of obesity and related diseases and non-therapeutic treatable conditions
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
KR101330190B1 (ko) 2011-09-20 2013-11-15 (주)그린솔루션스 하고초 추출물의 헴 옥시게나아제-1 발현 조절을 통한 지방 생성 억제용 화장료 조성물
EP2793848B1 (en) 2011-12-19 2019-06-26 Mary Kay, Inc. Navy bean extract to whiten the skin and improve skin tone
ITMI20121570A1 (it) * 2012-09-20 2014-03-21 Indena Spa Nuovi estratti di cynara scolimus, coffea spp. e olea europaea per il trattamento della sindrome metabolica
ITMI20121727A1 (it) * 2012-10-12 2014-04-13 Indena Spa Formulazioni per il trattamento e la prevenzione dell'obesita'
ITMI20121749A1 (it) * 2012-10-16 2014-04-17 Indena Spa Estratti di helianthus annuus utili nel trattamento della sindrome metabolica e nella diminuzione dell'indice glicemico di alimenti e procedimento per la loro preparazione e composizioni che li contengono
KR102323049B1 (ko) 2014-03-10 2021-11-05 마리 케이 인코포레이티드 피부 라이트닝 조성물
DE202014005450U1 (de) * 2014-07-04 2015-10-06 Ursapharm Arzneimittel Gmbh Lactosefreies Arzneimittel
US20160302451A1 (en) * 2015-04-16 2016-10-20 Michael Hudnall Medical Food for Patients with Chronic Liver Disease
FR3075570B1 (fr) 2017-12-22 2020-01-03 Agro Innovation International Stimulation de la nitrification d'un sol avec des compositions comprenant un extrait de plante
IT201900000367A1 (it) * 2019-01-10 2020-07-10 Altergon Sa Composizioni comprendenti un peptide in grado di stimolare la via del segnale gprc6a-dipendente
CN110433280A (zh) * 2019-09-11 2019-11-12 周口师范学院 植物血凝素在制备预防或治疗肥胖药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8524275D0 (en) * 1985-10-02 1985-11-06 Efamol Ltd Pharmaceutical & dietary compositions
DE19627376A1 (de) * 1996-07-06 1998-01-08 Aar Pharma Adler Apotheke Verwendung von Artischocken-(Cynara)-Extrakten
HRP990080B1 (en) * 1999-03-12 2003-04-30 Vladimir Leko Plant mixture and a medical preparation for the treatment of diabetes mellitus, type ii, obtained therefrom
US6818234B1 (en) * 1999-08-27 2004-11-16 Access Business Group International Llc Dietary food supplement containing natural cyclooxygenase inhibitors and methods for inhibiting pain and inflammation
ITMI20051347A1 (it) * 2005-07-14 2007-01-15 Indena Spa Estratti di cynara scolimus loro uso e formulazioni che li contengono
ITMI20052450A1 (it) 2005-12-22 2007-06-23 Indena Spa Estratti di phaseolus vulgaris loro uso e formulazioni che li contengono

Also Published As

Publication number Publication date
NO339322B1 (no) 2016-11-28
RU2453323C2 (ru) 2012-06-20
ATE431155T1 (de) 2009-05-15
AU2008224057A1 (en) 2008-09-12
AU2008224057B2 (en) 2012-07-19
JP2010520246A (ja) 2010-06-10
HK1121694A1 (en) 2009-04-30
IL200709A0 (en) 2010-05-17
PT1967198E (pt) 2009-06-15
IL200709A (en) 2013-07-31
US20100136145A1 (en) 2010-06-03
CA2680078C (en) 2016-12-06
US20080220097A1 (en) 2008-09-11
CN101641111B (zh) 2012-05-23
US7887855B2 (en) 2011-02-15
EP1967198A1 (en) 2008-09-10
DE602007001128D1 (de) 2009-06-25
JP5355424B2 (ja) 2013-11-27
KR20090118051A (ko) 2009-11-17
ES2323815T3 (es) 2009-07-24
WO2008107184A1 (en) 2008-09-12
SI1967198T1 (sl) 2009-08-31
NO20100527A1 (no) 2010-05-19
KR101456555B1 (ko) 2014-10-31
EP1967198B1 (en) 2009-05-13
BRPI0808563A2 (pt) 2014-09-02
PL1967198T3 (pl) 2009-10-30
US7887854B2 (en) 2011-02-15
RU2009133338A (ru) 2011-03-10
CN101641111A (zh) 2010-02-03
CA2680078A1 (en) 2008-09-12
BRPI0808563B1 (pt) 2018-02-14

Similar Documents

Publication Publication Date Title
DK1967198T3 (da) Formuleringer indeholdende Cynara scolymus- og Phaseolus vulgaris-ekstrakter, der er anvendelige til behandling af obesitet
CL2019001115A1 (es) Formulación líquida de un conjugado de insulina de acción prolongada. (divisional solicitud 201500177).
EP2638903A4 (en) GLYCEMIA ELEVATION SUPPRESSOR
MX2009010462A (es) Composiciones de alimento que incorporan trigliceridos de cadena media.
EA201101191A1 (ru) Фармацевтическая композиция, включающая ингибитор sglt-2, ингибитор дпп-iv и необязательно другой антидиабетический агент, и ее применение
UA116638C2 (uk) Композиція жирової суміші
ECSP13012661A (es) Composición farmacéutica, métodos de tratamiento y usos de la misma.
CL2008003582A1 (es) Uso de una composicion farmaceutica que contiene cisteamina o cistamina en la preparacion de un medicamento util para el tratamiento de una enfermedad de higado graso no alcholico (nafld) o esteatohepatitis no alcoholica (nash).
SV2011003829A (es) Derivados de pirazolo [3,4] pirimidin-4-ilo y sus usos para el tratamiento de la diabetes y la obesidad
EA200970238A1 (ru) ПРИМЕНЕНИЕ МАСЕЛ С DPA(n-6) В ДЕТСКОМ ПИТАНИИ
BRPI0508584A (pt) lipìdio estruturado contendo composições e métodos com caracterìsticas promotoras de saúde e nutrição
NO20076382L (no) Anvendelse av dokosaheksaenglyserider i behandlingen av tumorese sykdommer
ECSP099612A (es) Derivados de bencimidazol y sus métodos de uso
BRPI0806863B8 (pt) uso de um éster de forbol na preparação de um medicamento para prevenção ou tratamento de uma infecção por hiv
BR112012008280A2 (pt) Composição adesiva
BRPI0823082B8 (pt) composições de derivados de sesquiterpeno para prevenir ou tratar hiperlipidemia, fígado gordo, diabetes ou obesidade
BRPI0704008A2 (pt) uso de glicerina, método para tratamento de culturas, composição de mistura em tanque e um método para a preparação de uma composição de mistura em tanque
WO2007097523A3 (en) Fat composition and preparation methods thereof
BR112012012649A2 (pt) agente indutor de beta-defensina humana, formulação, e, usos de um agente indutor de beta-defensiva humana, e de pelo menos uma gordura ou óleo de um triglicerídeo de ácido graxo essencial ou de um derivado do mesmo.
WO2010108051A3 (en) Inhibitors of diacylglycerol o-acyltransferase 1(dgat-1) and uses thereof
IN2012DN00977A (sl)
WO2010041908A3 (ko) 판두라틴 유도체 또는 보에센베르기아 판두라타 추출물의 신규한 용도
WO2010133377A8 (en) Fat blends and uses thereof
BRPI0602179A (pt) composição farmacêutica compreendendo ciclobenzaprina e aceclofenaco em combinação
ATE464879T1 (de) Fettlösliche drogengestaltung